ConductScience.org, home

Paper3720173

Pharmacodynamics and side effects of flecainide acetate.

Salerno DM and 7 others. Clin Pharmacol Ther, 1986. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Pharmacodynamics and side effects of flecainide acetate. Papers, record 3720173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3720173

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacodynamics and side effects of flecainide acetate.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.29
iCite
Revised in PubMed
2019-05-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salerno DMD M
2Granrud GG
3Sharkey PP
4Krejci JJ
5Larson TT
6Erlien DD
7Berry DD
8Hodges MM

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arrhythmias, CardiacMajor topic
Cardiovascular DiseasesMajor topic
ElectrocardiographyMajor topic
PiperidinesMajor topic
Aged
Dose-Response Relationship, Drug
Female
Flecainide
Heart Ventricles
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
40300738Flecainide sensitizes conduction to hyponatremia through an ephaptic mechanism.Heart Rhythm2026https://conductscience.org/library/papers/40300738PubMed
39741635Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.Front Pharmacol2024https://conductscience.org/library/papers/39741635PubMed
36507291Electrocardiograms in Critical Care Cardiology.JACC Case Rep2022https://conductscience.org/library/papers/36507291PubMed
34026129Transition of maternal serum concentration of digoxin and flecainide in the third trimester-A case report of fetal supraventricular tachycardia with hydrops.Clin Case Rep2021https://conductscience.org/library/papers/34026129PubMed
31419329Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.Br J Clin Pharmacol2019https://conductscience.org/library/papers/31419329PubMed
25884086Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide.Neth Heart J2015https://conductscience.org/library/papers/25884086PubMed
25870032Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Eur J Clin Pharmacol2015https://conductscience.org/library/papers/25870032PubMed
22435343Safety of flecainide.Drug Saf2012https://conductscience.org/library/papers/22435343PubMed
21812498Is antiarrhythmic treatment in the elderly different? a review of the specific changes.Drugs Aging2011https://conductscience.org/library/papers/21812498PubMed
16944116Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.Eur J Clin Pharmacol2006https://conductscience.org/library/papers/16944116PubMed
15619132Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation.Eur J Clin Pharmacol2004https://conductscience.org/library/papers/15619132PubMed
8103355Clinical significance of genetic influences on cardiovascular drug metabolism.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8103355PubMed
3144374Is there a genetic factor in flecainide toxicity?BMJ1988https://conductscience.org/library/papers/3144374PubMed
2511912Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2511912PubMed
1906003Polymorphic flecainide disposition under conditions of uncontrolled urine flow and pH.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1906003PubMed
1782979Elimination of flecainide as a function of urinary flow rate and pH.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1782979PubMed
1451729The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1451729PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3720173

GET https://conductscience.org/api/papers/v1/3720173/authors